As on Wednesday, Mimedx Group Inc (NASDAQ: MDXG) got off with the flyer as it spiked 4.51% to $7.19, before settling in for the price of $6.88 at the close. Taking a more long-term approach, MDXG posted a 52-week range of $5.69-$10.14.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -4.02%. This publicly-traded company’s shares outstanding now amounts to $147.92 million, simultaneously with a float of $116.46 million. The organization now has a market capitalization sitting at $1.06 billion. At the time of writing, stock’s 50-day Moving Average stood at $6.97, while the 200-day Moving Average is $7.20.
Mimedx Group Inc (MDXG) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Mimedx Group Inc’s current insider ownership accounts for 21.29%, in contrast to 51.06% institutional ownership. According to the most recent insider trade that took place on May 02 ’25, this organization’s Chief Executive Officer bought 200,000 shares at the rate of 6.34, making the entire transaction reach 1,268,000 in total value, affecting insider ownership by 529,530. Preceding that transaction, on Mar 17 ’25, Company’s Chief Commercial Officer sold 1,759 for 8.04, making the whole transaction’s value amount to 14,142. This particular insider is now the holder of 309,077 in total.
Mimedx Group Inc (MDXG) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.07 per share during the current fiscal year.
Mimedx Group Inc’s EPS decrease for this current 12-month fiscal period is -4.02% and is forecasted to reach 0.32 in the upcoming year.
Mimedx Group Inc (NASDAQ: MDXG) Trading Performance Indicators
Let’s observe the current performance indicators for Mimedx Group Inc (MDXG). It’s Quick Ratio in the last reported quarter now stands at 3.90. Alongside those numbers, its PE Ratio stands at $33.33, and its Beta score is 1.68. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.92. Similarly, its price to free cash flow for trailing twelve months is now 18.27.
In the same vein, MDXG’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.22, a figure that is expected to reach 0.08 in the next quarter, and analysts are predicting that it will be 0.32 at the market close of one year from today.
Technical Analysis of Mimedx Group Inc (MDXG)
Through scrutinizing the latest numbers posted by the [Mimedx Group Inc, MDXG], it can be observed that its last 5-days Average volume of 1.02 million was better the volume of 0.67 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 78.17% While, its Average True Range was 68.67.
Raw Stochastic average of Mimedx Group Inc (MDXG) in the period of the previous 100 days is set at 63.64%, which indicates a major fall in contrast to 82.11% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.23 that was lower than 0.24 volatility it exhibited in the past 100-days period.
